Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) neutralization counteracts T cell immune evasion in breast cancer
Cristina Travelli(University of Pavia), Armando A. Genazzani(University of Turin), Francesca Fagiani(University of Pavia), Fabrizio Condorelli(Piedmont University), Sabina Sangaletti(Fondazione IRCCS Istituto Nazionale dei Tumori), Joe G. N. Garcia(Scripps Research Institute), Massimo Costanza(Fondazione IRCCS Istituto Neurologico Carlo Besta), Paola Portararo(Istituti di Ricovero e Cura a Carattere Scientifico), Nausicaa Clemente(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Giorgia Colombo(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Ambra A. Grolla(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Mario P. Colombo(University of Palermo), Natália de Melo Nasser Fava(University of Pavia), Martina Aliotta(University of Pavia), Rita De Sanctis(Humanitas University)
Cited by 19
Related Papers
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
|The Lancet Oncology|2017|493
Classification of current anticancer immunotherapies
|Oncotarget|2014|469
Association Between the MUC5B Promoter Polymorphism and Survival in Patients With Idiopathic Pulmonary Fibrosis
|JAMA|2013|456
Activated Protein C Mediates Novel Lung Endothelial Barrier Enhancement
|Journal of Biological Chemistry|2005|355
Peripheral Blood Mononuclear Cell Gene Expression Profiles Predict Poor Outcome in Idiopathic Pulmonary Fibrosis
|Science Translational Medicine|2013|350